452 related articles for article (PubMed ID: 29703751)
1. Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes.
Agwa AJ; Peigneur S; Chow CY; Lawrence N; Craik DJ; Tytgat J; King GF; Henriques ST; Schroeder CI
J Biol Chem; 2018 Jun; 293(23):9041-9052. PubMed ID: 29703751
[TBL] [Abstract][Full Text] [Related]
2. Gating modifier toxin interactions with ion channels and lipid bilayers: Is the trimolecular complex real?
Agwa AJ; Henriques ST; Schroeder CI
Neuropharmacology; 2017 Dec; 127():32-45. PubMed ID: 28400258
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7.
Agwa AJ; Tran P; Mueller A; Tran HNT; Deuis JR; Israel MR; McMahon KL; Craik DJ; Vetter I; Schroeder CI
J Biol Chem; 2020 Apr; 295(15):5067-5080. PubMed ID: 32139508
[TBL] [Abstract][Full Text] [Related]
4. A complicated complex: Ion channels, voltage sensing, cell membranes and peptide inhibitors.
Zhang AH; Sharma G; Undheim EAB; Jia X; Mobli M
Neurosci Lett; 2018 Jul; 679():35-47. PubMed ID: 29684532
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic Ligation of a Pore Blocker Toxin and a Gating Modifier Toxin: Creating Double-Knotted Peptides with Improved Sodium Channel Na
Tran HNT; Tran P; Deuis JR; Agwa AJ; Zhang AH; Vetter I; Schroeder CI
Bioconjug Chem; 2020 Jan; 31(1):64-73. PubMed ID: 31790574
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana.
Liu Z; Cai T; Zhu Q; Deng M; Li J; Zhou X; Zhang F; Li D; Li J; Liu Y; Hu W; Liang S
J Biol Chem; 2013 Jul; 288(28):20392-403. PubMed ID: 23703613
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Spider (
Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
[TBL] [Abstract][Full Text] [Related]
9. Potency-Enhancing Mutations of Gating Modifier Toxins for the Voltage-Gated Sodium Channel Na
Katz D; Sindhikara D; DiMattia M; Leffler AE
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800031
[TBL] [Abstract][Full Text] [Related]
10. Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin.
Xu H; Li T; Rohou A; Arthur CP; Tzakoniati F; Wong E; Estevez A; Kugel C; Franke Y; Chen J; Ciferri C; Hackos DH; Koth CM; Payandeh J
Cell; 2019 Feb; 176(4):702-715.e14. PubMed ID: 30661758
[TBL] [Abstract][Full Text] [Related]
11. Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus.
Cardoso FC; Dekan Z; Smith JJ; Deuis JR; Vetter I; Herzig V; Alewood PF; King GF; Lewis RJ
Br J Pharmacol; 2017 Aug; 174(15):2528-2544. PubMed ID: 28542706
[TBL] [Abstract][Full Text] [Related]
12. Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx-1.
Lawrence N; Wu B; Ligutti J; Cheneval O; Agwa AJ; Benfield AH; Biswas K; Craik DJ; Miranda LP; Henriques ST; Schroeder CI
ACS Chem Biol; 2019 Jan; 14(1):118-130. PubMed ID: 30507158
[TBL] [Abstract][Full Text] [Related]
13. µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects.
Zhang YX; Peng DZ; Zhang QF; Huang B; Yang QC; Tang DF; Chen MZ; Rong MQ; Liu ZH
Acta Pharmacol Sin; 2019 Jul; 40(7):859-866. PubMed ID: 30382183
[TBL] [Abstract][Full Text] [Related]
14. Lengths of the C-Terminus and Interconnecting Loops Impact Stability of Spider-Derived Gating Modifier Toxins.
Agwa AJ; Huang YH; Craik DJ; Henriques ST; Schroeder CI
Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28805686
[TBL] [Abstract][Full Text] [Related]
15. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
[TBL] [Abstract][Full Text] [Related]
16. Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency.
Peschel A; Cardoso FC; Walker AA; Durek T; Stone MRL; Braga Emidio N; Dawson PE; Muttenthaler M; King GF
J Med Chem; 2020 Nov; 63(21):12773-12785. PubMed ID: 33078946
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7.
Henriques ST; Deplazes E; Lawrence N; Cheneval O; Chaousis S; Inserra M; Thongyoo P; King GF; Mark AE; Vetter I; Craik DJ; Schroeder CI
J Biol Chem; 2016 Aug; 291(33):17049-65. PubMed ID: 27311819
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
[TBL] [Abstract][Full Text] [Related]
19. Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNa
Agwa AJ; Lawrence N; Deplazes E; Cheneval O; Chen RM; Craik DJ; Schroeder CI; Henriques ST
Biochim Biophys Acta Biomembr; 2017 May; 1859(5):835-844. PubMed ID: 28115115
[TBL] [Abstract][Full Text] [Related]
20. Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.
Klint JK; Smith JJ; Vetter I; Rupasinghe DB; Er SY; Senff S; Herzig V; Mobli M; Lewis RJ; Bosmans F; King GF
Br J Pharmacol; 2015 May; 172(10):2445-58. PubMed ID: 25754331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
